NOW APPROVED
To treat adult patients with polymyalgia rheumatica (PMR) who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper.
KEVZARA NATIONAL BROADCAST
A New Treatment Option for Adult Patients with Polymyalgia Rheumatica
who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper
KEVZARA is indicated for treatment of adult patients with:
Do not use KEVZARA in patients with known hypersensitivity to sarilumab or any of the inactive ingredients.
Advise patients to read the FDA-approved patient labeling (Medication Guide and Instructions for Use).
Please click here to see full Prescribing Information, including Boxed WARNING.
KEVZARA is indicated for treatment of adult patients with:
Do not use KEVZARA in patients with known hypersensitivity to sarilumab or any of the inactive ingredients.
Advise patients to read the FDA-approved patient labeling (Medication Guide and Instructions for Use).
Please click here to see full Prescribing Information, including Boxed WARNING.